Overview

A Study for Patients With Type 1 Diabetes

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
Comparison of blood glucose levels in patients with Type 1 diabetes when they take a new basal insulin analog and when they take insulin glargine
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Insulin
Insulin Glargine
Insulin, Globin Zinc